These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10809511)

  • 1. Neuromuscular blocking drugs for the new millennium: current practice, future trends--comparative pharmacology of neuromuscular blocking drugs.
    Donati F
    Anesth Analg; 2000 May; 90(5 Suppl):S2-S6. PubMed ID: 10809511
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapacuronium: clinical pharmacology.
    Mirakhur RK; McCourt KC
    Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
    Wight WJ; Wright PM
    Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent.
    Larijani GE; Zafeiridis A; Goldberg ME
    Pharmacotherapy; 1999 Oct; 19(10):1118-22. PubMed ID: 10512060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic-dynamic explanation of the rapid onset-offset of rapacuronium.
    Proost JH; Wright PM
    Eur J Anaesthesiol Suppl; 2001; 23():83-9. PubMed ID: 11766253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapacuronium bromide: a review of its use in anaesthetic practice.
    Onrust SV; Foster RH
    Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid onset/offset of rapacuronium bromide explained?
    Proost JH; Schiere S; Beaufort TM; Wierda JM
    Anesthesiology; 1999 Nov; 91(5):1554-5; author reply 1555-6. PubMed ID: 10551617
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapacuronium. Introduction.
    Bevan DR
    Anesth Analg; 2000 May; 90(5 Suppl):S1. PubMed ID: 10809510
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacology of the neuromuscular blocking agents.
    Larijani GE; Gratz I; Silverberg M; Jacobi AG
    DICP; 1991 Jan; 25(1):54-64. PubMed ID: 1672571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapacuronium (Org 9487): do we have a replacement for succinylcholine?
    Goulden MR; Hunter JM
    Br J Anaesth; 1999 Apr; 82(4):489-92. PubMed ID: 10472209
    [No Abstract]   [Full Text] [Related]  

  • 11. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacoeconomics of neuromuscular blocking drugs.
    Chiu JW; White PF
    Anesth Analg; 2000 May; 90(5 Suppl):S19-S23. PubMed ID: 10809514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Newly developed muscle relaxants].
    Fukushima K
    Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of pharmacokinetics and pharmacodynamics of vecuronium in children and adults.
    Xue F; Liu Q; Zou Q; Luo L
    Chin Med J (Engl); 1998 Jan; 111(1):84-5. PubMed ID: 10322663
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapacuronium: first experience in clinical practice.
    Bartkowski RR; Witkowski TA
    Eur J Anaesthesiol Suppl; 2001; 23():90-3. PubMed ID: 11766254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of ORG 7617, a short-acting non-depolarizing neuromuscular blocking agent.
    van den Broek L; Wierda JM; Proost JH; Hommes FD; Agoston S
    Eur J Clin Pharmacol; 1994; 46(3):225-9. PubMed ID: 7915236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precurarization and priming: a theoretical analysis of safety and timing.
    Kopman AF; Khan NA; Neuman GG
    Anesth Analg; 2001 Nov; 93(5):1253-6. PubMed ID: 11682407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on laryngeal muscles and intubating conditions with new generation muscle relaxants.
    Meistelman C
    Acta Anaesthesiol Belg; 1997; 48(1):11-4. PubMed ID: 9099303
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of preoperative anticonvulsant therapy on vecuronium-induced neuromuscular block under sevoflurane anesthesia: a retrospective clinical study.
    Kawamura G; Kitamura T; Ohno N; Tashiro Y; Asahara M; Sato K; Yamada Y
    Masui; 2013 Aug; 62(8):935-8. PubMed ID: 23984567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.